Effects of hydralazine and valproate on the expression of E-cadherin gene and the invasiveness of QBC939 cells

Frontiers of Medicine in China

Volumn 3, Issue 2, 2009, Pages 153-157

  Li, Hong ^a   Chen, Shaoqin ^a   Shu, Yi ^a   Chen, Yongjun ^a   Su, Ying ^a   Wang, Xin ^a   Zou, Shengquan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bile duct carcinoma; DNA methylation inhibitor; E cadherin; Histone deacetylase inhibitor

Indexed keywords

EID: 67349173540     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-009-0034-5     Document Type: Article

References (19)

1. Birchmeiev W, Behrens J. Cadherin expression in carcinomas: Role of the formation of cell junction and the prevention of invasiveness. Biochim Biophys Acta, 1994, 1198(1):11-26
2. Liotta L A, Steeg P S, Stetler-Stevenson W G. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell, 1991, 64(2):327-336
3. Mareel M, Bracke M, Van Roy F. Cancer metastasis: Negative regulation by an invasion-suppressor complex. Cancer Detect Prev, 1995, 19(5):451-464
4. Berx G, Van Roy F. The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res, 2001, 3(5):289-293
5. Li Q, Wang J M, Liu C, Xiao B L, Su Y, Zou S Q. Expression and significance of aPKC-i and E-cadherin in Cholangiocarcinoma. Ai Zheng, 2007, 26(7):715-718 (in Chinese)
6. Tamura G, Yin J, Wang S, Fleisher A S, Zou T, Abraham J M, Kong D, Smolinski K N, Wilson K T, James S P, Silverberg S G, Nishizuka S, Terashima M, Motoyama T, Meltzer S J. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst, 2000, 92(7):569-573
7. Zochbauer-Muller S, Fong K M, Virmani A K, Geradts J, Gazdar A F, Minna J D. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res, 2001, 61(1):249-255
8. Yang B, House M G, Guo M, Herman J G, Clark D P. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma. Mod Pathol, 2005, 18(3):412-420
9. Jones PA, Baylin S B. The fundamental role of epigenetic events in cancer. Nat Rev Genet, 2002, 3(6):415-428
10. Zhu W G, Otterson G A. The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells. Curr Med Chem Anti-Cancer Agents, 2003, 3 (3):187-199
11. de la Cruz-Hernández E, Pérez-Cárdenas E, Contreras-Paredes A, Cantú D, Mohar A, Lizano M, Dueñas-González A. The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study. Virol J, 2007, 4: 18
12. Herman J G, Graff J R, Myohanen S, Nelkin B D, Baylin S B. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A, 1996, 93(18):9821-9826
13. Yap A S, Brieher W M, Gumbiner B M. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol, 1997, 13: 119-146
14. Mikami T, Saegusa M, Mitomi H, Yanaqisawa N, Ichinoe M, Okayasu I. Significant Correlations of E-Cadherin, Catenin, and CD44 Variant Form Expression With Carcinoma Cell Differentiation and Prognosis of Extrahepatic Bile Duct Carcinomas. Am J Clin Pathol, 2001, 116(3):369-376
15. Joo Y E, Rew J S, Park C S, Kim S J. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma. Pancreatology, 2002, 2(2):129-137
16. Berx G, Cleton-Jansen A M, Nollet F, de Leeuw W J, van de Vijver M, Cornelisse, C, van Roy F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J, 1995, 14(24):6107-6115
17. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 1991, 66(1):107-119
18. Asayama Y, Taguchi Ki K, Aishima Si S, Nishi H, Masuda K, Tsuneyoshi M. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: An immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin. Liver, 2002, 22(1):43-50
19. Sharma D, Blum J, Yang X, Beaulieu N, Macleod A R, Davidson N E. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells. Mol Endocrinol, 2005, 19 (7):1740-1751